Whitegate Investment Counselors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Whitegate Investment Counselors's BIIB Position: Q4 2021 in Review
Whitegate Investment Counselors sold out of Biogen (BIIB) in Q4 2021, closing a stake of 744 shares — an estimated $211K sold.
Whitegate Investment Counselors first reported a position in BIIB in Q3 2016 and held it in 13 quarters. The position peaked at $327K in Q4 2017. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q4 2021.
- Whitegate Investment Counselors reported no remaining Biogen position as of Q4 2021 after selling out during the quarter.
- Whitegate Investment Counselors sold 744 Biogen shares in Q4 2021, an estimated $211K.
- Whitegate Investment Counselors first reported a position in Biogen in Q3 2016 and held it in 13 quarters.
- Whitegate Investment Counselors's Biogen position peaked at $327K in Q4 2017.
- 1,009 funds tracked by Wall St. Rank held Biogen as of Q4 2021.
Based on Whitegate Investment Counselors's 13F filing for Q4 2021, filed 3 Feb 2022.